Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis

Background: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve th...

Full description

Bibliographic Details
Main Authors: Carlo Augusto Mallio, Andrea Napolitano, Gennaro Castiello, Francesco Maria Giordano, Pasquale D'Alessio, Mario Iozzino, Yipeng Sun, Silvia Angeletti, Marco Russano, Daniele Santini, Giuseppe Tonini, Bruno Beomonte Zobel, Bruno Vincenzi, Carlo Cosimo Quattrocchi
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/4/652
_version_ 1797413788666822656
author Carlo Augusto Mallio
Andrea Napolitano
Gennaro Castiello
Francesco Maria Giordano
Pasquale D'Alessio
Mario Iozzino
Yipeng Sun
Silvia Angeletti
Marco Russano
Daniele Santini
Giuseppe Tonini
Bruno Beomonte Zobel
Bruno Vincenzi
Carlo Cosimo Quattrocchi
author_facet Carlo Augusto Mallio
Andrea Napolitano
Gennaro Castiello
Francesco Maria Giordano
Pasquale D'Alessio
Mario Iozzino
Yipeng Sun
Silvia Angeletti
Marco Russano
Daniele Santini
Giuseppe Tonini
Bruno Beomonte Zobel
Bruno Vincenzi
Carlo Cosimo Quattrocchi
author_sort Carlo Augusto Mallio
collection DOAJ
description Background: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve the challenge of differential diagnosis between COVID-19 pneumonia and ICI therapy-related pneumonitis. Methods: We enrolled three groups: a pneumonia-free group (<i>n</i> = 30), a COVID-19 group (<i>n</i> = 34), and a group of patients with ICI therapy-related pneumonitis (<i>n</i> = 21). Computed tomography images were analyzed with an artificial intelligence (AI) algorithm based on a deep convolutional neural network structure. Statistical analysis included the Mann–Whitney U test (significance threshold at <i>p</i> < 0.05) and the receiver operating characteristic curve (ROC curve). Results: The algorithm showed low specificity in distinguishing COVID-19 from ICI therapy-related pneumonitis (sensitivity 97.1%, specificity 14.3%, area under the curve (AUC) = 0.62). ICI therapy-related pneumonitis was identified by the AI when compared to pneumonia-free controls (sensitivity = 85.7%, specificity 100%, AUC = 0.97). Conclusions: The deep learning algorithm is not able to distinguish between COVID-19 pneumonia and ICI therapy-related pneumonitis. Awareness must be increased among clinicians about imaging similarities between COVID-19 and ICI therapy-related pneumonitis. ICI therapy-related pneumonitis can be applied as a challenge population for cross-validation to test the robustness of AI models used to analyze interstitial pneumonias of variable etiology.
first_indexed 2024-03-09T05:23:54Z
format Article
id doaj.art-04f0c8c0e6994226b4160329f15c91ed
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T05:23:54Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-04f0c8c0e6994226b4160329f15c91ed2023-12-03T12:38:20ZengMDPI AGCancers2072-66942021-02-0113465210.3390/cancers13040652Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related PneumonitisCarlo Augusto Mallio0Andrea Napolitano1Gennaro Castiello2Francesco Maria Giordano3Pasquale D'Alessio4Mario Iozzino5Yipeng Sun6Silvia Angeletti7Marco Russano8Daniele Santini9Giuseppe Tonini10Bruno Beomonte Zobel11Bruno Vincenzi12Carlo Cosimo Quattrocchi13Departmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartment of Interventional Radiology, S. Maria Goretti Hospital, 04100 Latina, ItalyInfervision Europe GmbH, Mainzer Strasse 75, D-65189 Wiesbaden, GermanyDepartmental Faculty of Medicine and Surgery, Unit of Clinical Laboratory Science, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Medical Oncology, 00128 Rome, ItalyDepartmental Faculty of Medicine and Surgery, Unit of Diagnostic Imaging and Interventional Radiology, Università Campus Bio-Medico di Roma, 00128 Rome, ItalyBackground: Coronavirus disease 2019 (COVID-19) pneumonia and immune checkpoint inhibitor (ICI) therapy-related pneumonitis share common features. The aim of this study was to determine on chest computed tomography (CT) images whether a deep convolutional neural network algorithm is able to solve the challenge of differential diagnosis between COVID-19 pneumonia and ICI therapy-related pneumonitis. Methods: We enrolled three groups: a pneumonia-free group (<i>n</i> = 30), a COVID-19 group (<i>n</i> = 34), and a group of patients with ICI therapy-related pneumonitis (<i>n</i> = 21). Computed tomography images were analyzed with an artificial intelligence (AI) algorithm based on a deep convolutional neural network structure. Statistical analysis included the Mann–Whitney U test (significance threshold at <i>p</i> < 0.05) and the receiver operating characteristic curve (ROC curve). Results: The algorithm showed low specificity in distinguishing COVID-19 from ICI therapy-related pneumonitis (sensitivity 97.1%, specificity 14.3%, area under the curve (AUC) = 0.62). ICI therapy-related pneumonitis was identified by the AI when compared to pneumonia-free controls (sensitivity = 85.7%, specificity 100%, AUC = 0.97). Conclusions: The deep learning algorithm is not able to distinguish between COVID-19 pneumonia and ICI therapy-related pneumonitis. Awareness must be increased among clinicians about imaging similarities between COVID-19 and ICI therapy-related pneumonitis. ICI therapy-related pneumonitis can be applied as a challenge population for cross-validation to test the robustness of AI models used to analyze interstitial pneumonias of variable etiology.https://www.mdpi.com/2072-6694/13/4/652artificial intelligenceCOVID-19deep learningchest CTimmune checkpoint inhibitors therapydrug-induced pneumonitis
spellingShingle Carlo Augusto Mallio
Andrea Napolitano
Gennaro Castiello
Francesco Maria Giordano
Pasquale D'Alessio
Mario Iozzino
Yipeng Sun
Silvia Angeletti
Marco Russano
Daniele Santini
Giuseppe Tonini
Bruno Beomonte Zobel
Bruno Vincenzi
Carlo Cosimo Quattrocchi
Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
Cancers
artificial intelligence
COVID-19
deep learning
chest CT
immune checkpoint inhibitors therapy
drug-induced pneumonitis
title Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
title_full Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
title_fullStr Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
title_full_unstemmed Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
title_short Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis
title_sort deep learning algorithm trained with covid 19 pneumonia also identifies immune checkpoint inhibitor therapy related pneumonitis
topic artificial intelligence
COVID-19
deep learning
chest CT
immune checkpoint inhibitors therapy
drug-induced pneumonitis
url https://www.mdpi.com/2072-6694/13/4/652
work_keys_str_mv AT carloaugustomallio deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT andreanapolitano deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT gennarocastiello deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT francescomariagiordano deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT pasqualedalessio deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT marioiozzino deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT yipengsun deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT silviaangeletti deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT marcorussano deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT danielesantini deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT giuseppetonini deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT brunobeomontezobel deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT brunovincenzi deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis
AT carlocosimoquattrocchi deeplearningalgorithmtrainedwithcovid19pneumoniaalsoidentifiesimmunecheckpointinhibitortherapyrelatedpneumonitis